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Hypercalcemia Associated with Acute Kidney Injury 
and Metabolic Alkalosis
Most cases of hypercalcaemia are secondary to malignancy or primary hyper­
para  thyroidism. We report a patient presenting with a triad of hypercalcemia, 
metabolic alkalosis, and renal failure secondary to treatment of iatrogenic 
hypoparathyroidism and osteoporosis. Persistent ingestion of calcium carbonate 
and vitamin D caused milk­alkali syndrome. The patient was managed with 
intravenous fluids and withdrawal of calcium carbonate and vitamin D. She 
responded well to the treatment and the calcium concentration, renal function 
and metabolic alkalosis were normalized. Milk­alkali syndrome may be important 
as a reemerging cause of hypercalcemia.
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Introduction
Most cases of hypercalcemia are secondary to malig­
nancy or primary hyperparathyroidism
1). Milk­alkali 
syn  drome previously accounted for about 12% of cases 
and ranks the third among the causes of hypercalcemia in 
hospitalized patients
2). The syndrome consists of the triad of 
hypercalcemia, metabolic alkalosis, and renal insufficiency 
associated with ingestion of large amount of calcium and 
absorbable alkali. After the advent of non absorbable 
antacids and later histamine­2 blockers, the incidence of 
this syndrome dropped to less than 1% of etiologies of 
hypercalcemia in the mid­seventies
3). However, recently 
the incidence has increased secondary to the use of calcium 
carbonate for the prevention and treatment of osteoporosis 
and hyperphosphataemia in patients with chronic kidney 
disease
4). We report a case of milk­alkali syndrome 
secondary to ingestion of calcium carbonate and vitamin 
D, in addition to taking bisphosphonate, and iatrogenic 
hypoparathyroidism.
Case Report
An 80­year­old female visited our hospital with a one­
week history of nausea and general weakness. Her past 
medical history included a total thyroidectomy 10 years 
ago for papillary thyroid carcinoma. She had been taking 
levothyroxine for iatrogenic hypothyroidism, calcium 
carbonate (3.0 g daily) and active vitamin D (1.5 μg daily) 
for iatrogenic hypoparathyroidism, and bisphosphonate 
for osteoporosis. Her pulse was 68/min, blood pressure 
130/80 mmHg, body temperature 36.9℃, and her skin 
turgor was decreased. Urinalysis was within the normal 
range except for the red blood cell count, 8–10/HPF. The 
pertinent laboratory tests revealed severe hypercalcemia, 
acute kidney injury and metabolic alkalosis (Table 1). Her 
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chest computed tomography, protein electrophoresis, 
eso  phagoduodenoscopy were non­specific. She was 
initially managed with 3 L of saline solution, 20 mg of 
furosemide administered intravenously and withdrawal 
of calcium carbonate and vitamin D. She responded well 
to aggressive intravenous fluid administration and the 
calcium concentration fell rapidly. Three days later, nausea 
and other symptoms improved, and her hypercalcemia, 
metabolic alkalosis and renal function were normalized 
(Table 1). 
 Discussion
Milk­alkali syndrome consists of the triad of hyper­
calcemia, metabolic alkalosis, and renal insufficiency 
asso  ciated with ingestion of large amount of calcium and 
absorbable alkali. Our patient had profound symptomatic 
hypercalcemia, which caused gastrointestinal symptoms 
and muscle weakness. Work­up for malignancy was 
negative and a thorough history taking revealed calcium 
and alkali ingestion. The clinical laboratory data showed 
characteristics of milk­alkali syndrome and we excluded 
other causes of hypercalcemia
5). 
In the early 20th century, calcium­containing antacids 
and milk were used to treat peptic ulcer disease. Sometimes 
this therapy was associated with toxicity. Hardt and Rivers 
identified milk­alkali syndrome in 1923 and reported 
that it caused headache, nausea, vomiting, dizziness, 
musculoskeletal pains, and weakness
6). By 1985, milk­alkali 
syndrome was considered as less than one percent of cases 
of hypercalcemia. However, there has been a resurgence 
of this disorder, probably secondary to the use of calcium 
carbonate for osteoporosis and hyperphosphataemia in 
patients with chronic kidney disease
4). Therefore, some 
recommend that the term “calcium­alkali syndrome”, 
which broadens the definition of the condition, should 
replace milk­alkali syndrome, since the term “milk­alkali 
syndrome” no longer reflects the etiologic origin
7). 
The pathophysiology of the milk­alkali syndrome is 
poorly understood. It is unclear why only some individuals 
are affected by excessive ingestion, but it has been suggested 
that they absorb more calcium than others
8). Patients who 
appear to be at high risk for milk­alkali syndrome include 
old age, volume depletion and medication that reduces 
glomerular filtration rate, such as angiotensin converting 
enzyme inhibitors, angiotensin receptor blockers or non­
steroidal anti­inflammatory agents
8). Hypercalcemia 
causes reduced glomerular filtration rate, increased sodium 
excretion and depletion of total body water, leading to in­
creased bicarbonate reabsorption and metabolic alkalosis,. 
Alkalosis enhances calcium reabsorption in the distal 
nephron, thus, aggravating the hypercalcemia
8, 9). 
As for the management, withdrawal of the offending 
agent and intravenous volume expansion are the most 
initial steps. Usually, these interventions will reverse 
hypercalcemia and alkalosis. Renal function can return to 
normal if the diagnosis of milk alkali syndrome is made 
early in the course of the disease. Hemodialysis may be 
required in some clinical settings. In conclusion, milk alkali 
syndrome may be important as a reemerging cause of 
hypercalcemia. A detailed history, including the use of over­
the­counter medication, should be taken in all patients. 
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pCO2 (mmHg)
Bicarbonate (mEq/L)
Sodium (mEq/L)
Potassium (mEq/L)
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Phosphate (mg/dL)
PTH (pg/mL)
TSH (uIU/mL)
Free T4 (ng/dL)
0.5–1.2
8–23
8.4–10.2
1.9–2.5
3.5–5
7.35–7.45
38–48
21–28
135–145
3.5–5
1.9–2.5
2.5–5.5
9–55
0.35–5.5
0.8–1.54
1.4
22.1
13.2
3.4
4.1
7.48
42.3
30.7
138
3.3
2.2
4.1
1
< 0.01
2.04
0.7
10.3
6.6
2.0
3.2
7.47
37.8
27.6
141
3.7
1.4
2.0
-
-
-
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